Navigation Links
Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
Date:3/3/2008

the acute treatment of migraine headaches has completed Phase 2 testing. AZ-104 (Staccato loxapine) for the acute treatment of migraine headaches and AZ-002 (Staccato alprazolam) for the acute treatment of panic attacks associated with panic disorder are in Phase 2 testing. Product candidates in Phase 1 testing include AZ-003 (Staccato fentanyl) for the treatment of breakthrough pain, which is partnered with Endo Pharmaceuticals in North America, and AZ-007 (Staccato zaleplon) for the treatment of insomnia. More information, including this and past press releases from Alexza is available online at http://www.alexza.com.

Safe Harbor Statement

This press release includes forward-looking statements regarding the development, therapeutic potential and safety of AZ-104, the development of the Company's product candidates, projected clinical trial enrollment and data reporting timelines, and safety of the Company's products and technologies. Any statement describing the Company's expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs. The Company's forward-looking statements also involve assumptions that, if they prove incorrect, would cause its results to differ materially from those expressed or implied by such forward-looking statements. These and other risks concerning Alexza's business are described in additional detail in the Company's Annual Report on Form 10-K/A for the year ended December 31, 2006, and the Company's other Periodic and Current Reports filed with the Securities and Exchange Commission, including the risks under the headings: "Failure or delay in commencing or completing clinical trials for our product candidates could harm our
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
5. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
9. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
10. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
11. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Pa. , June 2, 2015  Integrated Service Solutions, Inc. ("the Company") announced today they are expanding their reach nationally ... http://photos.prnewswire.com/prnh/20150601/219766 ... ... ... ...
(Date:6/2/2015)... -- CytRx Corporation (NASDAQ: CYTR ), a biopharmaceutical research ... it has reached an agreement to settle the stockholder ... Court of Chancery, which names as defendants a ... officers, and names the Company as a nominal defendant. ... Corp. Stockholder Derivative Litigation , C.A. No. 9864-VCL, relates ...
(Date:6/2/2015)... , June 2, 2015  Psychemedics Corporation (NASDAQ: ... over twenty-five years, announced the addition of 2 new ... to growing abuse concerns, the addition of Oxymorphone was ... was added as an option to the Amphetamine panel. ... CEO stated:  "Sadly, more and more prescription drugs are ...
Breaking Medicine Technology:Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 2Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 3Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 4CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 2CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 3CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 4Psychemedics Announces Addition Of FDA Cleared Drugs 2Psychemedics Announces Addition Of FDA Cleared Drugs 3
... ROCKVILLE, Md., June 20, 2011 Neuralstem, Inc. (NYSE Amex: ... to dose the final cohort in the ongoing Phase Ia ... of major depression. Phase Ia is testing the drug in ... new chemical entity discovered by Neuralstem that stimulates new neuron ...
... 2011 ActiveCare, Inc. (ACAR.OB) a leader in senior ... to head up the rollout of ActiveCare,s ActiveHome products ... the market its, comprehensive ActiveHome Monitoring System.  To guide ... who with his team has extensive experience increasing sales ...
Cached Medicine Technology:Neuralstem Updates NSI-189 Major Depression Trial 2Neuralstem Updates NSI-189 Major Depression Trial 3With Launch of New ActiveHome Monitoring System, ActiveCare Announces New Head of Sales and Marketing 2With Launch of New ActiveHome Monitoring System, ActiveCare Announces New Head of Sales and Marketing 3
(Date:6/3/2015)... 03, 2015 DailyEndorphin is pleased to ... module. With this highly configurable new offering, DE's ... on many components of its wellness programming for the ... charge. , With this new module, annual clients may ... (2) Create participant surveys, (3) Continually report on participant ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 “ Scanalytics ... monthly Tech Report, which features the latest and coolest ... expert and the host of NewsWatch, conducted the review ... to analyze floor traffic in retail stores. , Tracking ... an enterprise. When it comes to retail this goes ...
(Date:6/3/2015)... Fit Body Boot Camp is America’s fastest ... helps thousands of individuals across the country lose weight and ... the gym and get the fitness results they want the ... out any gym membership: , Tip #1 – Don’t do ... is saying motivated and on track. Attempting to overcome these ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 Come on ... Relay , a 200-mile overnight relay beginning in Madison, ... Illinois on Saturday, June 13th. , For the 4th ... the Brainstormers will run to raise money for the ... of different members of the Neurosurgery staff from The ...
(Date:6/3/2015)... June 03, 2015 Unfortunately, a majority of ... comes to providing comfort to the users throughout the year. ... or one from the local market, the makers generally tend ... in the process, often overlook comfort and health. To counter ... shoe, the creative heads at Vay Technologies have come up ...
Breaking Medicine News(10 mins):Health News:DailyEndorphin Launches Wellness "Events" Portal 2Health News:Technology to Analyze Foot Traffic in Retail Stores was featured on NewsWatch Television 2Health News:Summer Body Slim-Down: 5 Ways to Avoid Quitting Gym Memberships this Summer 2Health News:Summer Body Slim-Down: 5 Ways to Avoid Quitting Gym Memberships this Summer 3Health News:4th Annual Ragnar Relay from Madison, WI to Chicago, IL Once Again Benefits Renowned Brain Aneurysm Foundation 2Health News:Vay Technologies Launches uGALE the High Tech Insole Technology for Shoes on KickStarter 2Health News:Vay Technologies Launches uGALE the High Tech Insole Technology for Shoes on KickStarter 3
... ... and the UCSF Helen Diller Family Comprehensive Cancer Center at UCSF Medical Center have ... and express referrals to cancer specialists through a convenient Napa Valley location. , ... (Vocus) January 12, 2010 -- The Martin-O’Neil ...
... , WASHINGTON , Jan. 12 ... District Court in Miami to participating in a conspiracy to ... of the Criminal Division; U.S. Attorney Terrence I. Berg ... , Special Agent-in-Charge of the FBI,s Detroit Field Office; and Daniel ...
... , NEW YORK , Jan. 12 ... a down dog yoga pose, as much energy as a ... in Times Square- and yes you can actually lose weight too. ... combines nutrition, in home fitness, pilates, acupuncture, private cooking classes, massage ...
... even small amount of amyloid plaques affected olfactory sense, , ... suggests that loss of smell could serve as an early ... known to suffer from loss of smell. But the new ... -- the bits of gunk in the brain that cause ...
... ... "Do Not Call" compliance solutions, announced today the availability of SmartBlock (TM), a new ... while eliminating the risk of sales agents contacting a consumer who has been listed ... ...
... , WASHINGTON , Jan. 12 ... in of Jeff Borns as mission director to ... presided over the event and administered the oath to Borns. , ... South Africa , Borns will oversee a program exceeding $500 ...
Cached Medicine News:Health News:St. Helena Hospital Cancer Center Affiliates with the UCSF Medical Center to Enhance Local Cancer Care 2Health News:St. Helena Hospital Cancer Center Affiliates with the UCSF Medical Center to Enhance Local Cancer Care 3Health News:Clinic Manager Pleads Guilty in Medicare Fraud Scheme 2Health News:Clinic Manager Pleads Guilty in Medicare Fraud Scheme 3Health News:The Search For the Fountain of Weight Loss ends with Mindful Health's Body Balance Program 2Health News:Contact Center Compliance Launches New Sales Agent Productivity Tool: "SmartBlock (TM)" 2Health News:Contact Center Compliance Launches New Sales Agent Productivity Tool: "SmartBlock (TM)" 3Health News:New USAID Mission Director for South Africa Sworn In 2
The DEI 750 MD from Optronics is a surgical 3 CCD color microscope camera with a 10 meter head cable. Easily mounts on your microscopes C-mount adapter and is the best choice for your surgical imagin...
... The Optronics MicroFire - ... 2-Megapixel Monochrome microscope camera with ... provides high-efficiency imaging beyond 900nm. ... microscope with a C-mount adapter ...
... Optronics MacroFIRE monochrome represents the ... leader in advanced scientific grade ... monochrome is a versatile CCD ... analysis in low-light, darkfield, fluoresence ...
The Optronics MacroFIRE represents the latest innovation from the world leader in advanced scientific grade CCD imaging for microscopy. MacroFIRE is a versatile CCD camera developed exclusively for c...
Medicine Products: